Diagnostic Approach to Atypical Enhancing Liver Lesions

Characterization of Liver Lesions

The American College of Radiology recommends that hemangiomas are characterized by peripheral nodular enhancement with progressive centripetal fill-in during arterial phase and hyperenhancement during venous and late phases, with 88-90% sensitivity and 99% specificity 1, 2
Focal Nodular Hyperplasia (FNH) typically shows intense arterial phase enhancement becoming isoattenuating to liver in portal venous phase, often with a central scar, as per the American Association for the Study of Liver Diseases 3
Cysts are non-enhancing, thin-walled with homogenous low-density interior, according to the American Association for the Study of Liver Diseases 3

Atypical enhancing lesions may indicate potential malignancy, such as hepatocellular carcinoma (HCC), which typically enhances in arterial phase and becomes hypoattenuating in portal venous phase, as stated by the American Association for the Study of Liver Diseases 4, 3
Metastatic disease can present with variable enhancement patterns depending on the primary tumor, often hypovascular but can be hypervascular with certain primaries, according to the American Association for the Study of Liver Diseases 3
Cholangiocarcinoma usually appears solid with minimal vascular enhancement, as per the American Association for the Study of Liver Diseases 3

The American College of Radiology suggests performing multiphasic contrast-enhanced MRI for indeterminate lesions, which provides superior characterization of liver lesions 1, 5
For lesions ≤2 cm deemed indeterminate on CT, MRI is necessary to establish diagnosis, particularly when malignancy is suspected, as recommended by the American College of Radiology 2
The addition of hepatobiliary phase imaging improves sensitivity and accuracy for nodules <2 cm, according to the American College of Radiology 6
Consider patient risk factors, such as cirrhosis, history of malignancy, and patient demographics, when evaluating atypical enhancing lesions, as stated by the American Association for the Study of Liver Diseases 4, 6
Utilize advanced imaging techniques, such as contrast-enhanced ultrasound (CEUS) and FDG-PET/CT, when appropriate, as recommended by the American College of Radiology 1, 2, 7
Consider image-guided biopsy when imaging features remain indeterminate despite advanced imaging, as suggested by the American College of Radiology 2, 5

Single-phase CT is inadequate for proper characterization of liver lesions; multiphasic imaging is essential, as stated by the American Association for the Study of Liver Diseases 4
Overlooking patient context, including underlying liver disease, history of malignancy, and patient demographics, can lead to misdiagnosis, according to the American Association for the Study of Liver Diseases 3
Misinterpreting transient enhancement differences in cirrhotic livers can cause artifacts that mimic lesions, as per the American College of Radiology 6
Inadequate biopsy sampling can lead to false negatives, as stated by the American College of Radiology 5
Overreliance on a single imaging modality can lead to misdiagnosis; combining different modalities often provides complementary information for difficult cases, as recommended by the American College of Radiology 1, 2, 5